Newly Approved Lumakras (sotorasib) Fights Lung Cancer Tied to Certain Genes

FRIDAY, June 4, 2021 — A newly approved lung cancer drug shows promise in improving survival in patients whose tumors carry a common and tough-to-treat genetic mutation, researchers say.
Sotorasib — brand name Lumakras — was approved…
Source: Topamax